Skip to Main Content

Paper Details

Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.
Hepatol Commun
4
2023
EBR, Elbasvir, GZR, HCV, HCV RNA, HCV infection, Headache, adolescent, children, chronic HCV, chronic HCV genotype 1 or 4 infection, elbasvir, fatigue, grazoprevir, nausea, participant, participants
Author NameAffiliation
Robert H SquiresUniversity of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh
Robert H SquiresUniversity of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh
Philip J RosenthalUniversity of California san francisco
Daniel I S RosenbloomMerck & Co. Inc.
  • 1 - 4

Datasets

Release 1.2